SCHEMBL17792575

SCHEMBL17792575

CC(=O)NCc1c(CN2CCCC2)n(C)[nH]c1=O

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 1/20 0.36
▸ ALDH1A1 P00352 1/20 0.36
▸ MTNR1A P48039 2/20 0.34
▸ MTNR1B P49286 2/20 0.34
▸ NPSR1 Q6W5P4 1/20 0.33
▸ MAPT P10636 1/20 0.33
▸ NPC1 O15118 1/20 0.31
▸ PABPC1 P11940 1/20 0.31
▸ CYP2D6 P10635 3/20 0.31
▸ OPRK1 P41145 2/20 0.31
▸ OPRM1 P35372 1/20 0.31
▸ OPRD1 P41143 1/20 0.31
▸ HTR2A P28223 1/20 0.31
▸ HTR2C P28335 1/20 0.31
▸ HTR2B P41595 1/20 0.31
▸ ALOX15 P16050 1/20 0.31
▸ ACACB O00763 1/20 0.30
▸ CYP1A2 P05177 1/20 0.30
▸ CYP2C19 P33261 1/20 0.30
▸ L3MBTL1 Q9Y468 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17792540 0.88 MTNR1B (0.36) ALDH1A1MTNR1B
SCHEMBL17789034 0.86 DRD4 (0.32) ALDH1A1MAPT
SCHEMBL18743918 0.85 MAPT (0.33) KDM4EALDH1A1MAPTPABPC1ALOX15
SCHEMBL17792491 0.80 CYP1A2 (0.33) NPSR1CYP1A2CYP2C19
SCHEMBL17792544 0.78 ALDH1A1 (0.36) KDM4EALDH1A1NPSR1MAPTHTR2A
SCHEMBL17792545 0.77 ALDH1A1 (0.39) KDM4EALDH1A1NPSR1MAPTHTR2A
SCHEMBL17792539 0.75 KMT2A (0.34) NPSR1MAPTNPC1CYP2D6OPRK1
SCHEMBL17792509 0.73 CYP1A2 (0.34) KDM4EALDH1A1NPSR1MAPTALOX15
SCHEMBL17792498 0.72 DHODH (0.37) KDM4EALDH1A1NPSR1CYP2D6OPRK1
SCHEMBL17792494 0.70 TP53 (0.33) MTNR1AMTNR1BNPSR1CYP1A2CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170217941-A1 SUBSTITUTED BENZENE AND 6,5-FUSED BICYCLIC HETEROARYL COMPOUNDS Epizyme, Inc. 2017-08-03 — — US disclosed
US-9624205-B2 Substituted 6,5-fused bicyclic heteroaryl compounds Epizyme, Inc. (US) 2017-04-18 — — US disclosed
US-20160152604-A1 SUBSTITUTED 6,5-FUSED BICYCLIC HETEROARYL COMPOUNDS Epizyme, Inc. 2016-06-02 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160152604-A1 SUBSTITUTED 6,5-FUSED BICYCLIC HETEROARYL COMPOUNDS H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, CYP3A5, PAICS KDM4E 1368/4885ALDH1A1 552/4885MTNR1A 1946/4885
US-20170217941-A1 SUBSTITUTED BENZENE AND 6,5-FUSED BICYCLIC HETEROARYL COMPOUNDS BCOR, CYP2B6, AHR KDM4E 860/4885ALDH1A1 737/4885MTNR1A 2252/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback